Skip to content

Role of Walking and khadiradi tablet in diabetes

Efficacy of Khadiradi Ghanvati and Chankraman in the Management of Madhumeha (Type 2 Diabetes)- An Open Randomized Comparative Clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/06/019580
Enrollment
40
Registered
2019-06-10
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: khadiradi ghanvati: Ghanvati (Tablet) Dose 2 Tab(500mg) Frequency twice a day Route of administration Oral Anupana Jala Duration 56 Days Control Intervention1: chankraman(Walking): 3

Sponsors

Director IPGT and RA GAU Jamnagar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of both male and female sexes from age group 20-60 years. 2. Signs and symptoms of Madhumeha. 3. Fasting Blood Plasma glucose. >=7.0mmol/l (126mg/dl) OR Post Prandial Blood Plasma Glucose >=11.1mmol/l (200mg/dl). 4. BMI >= 23 Kg/m2 to 30 Kg/m2 5. Diagnosed cases who are not practicing 6 km regular walk

Exclusion criteria

Exclusion criteria: 1. Patients of Diabetes mellitus receiving Insulin. 2. Patients having chronic complications of Diabetes mellitus. 3. Micro vascular Retinopathy, Neuropathy and Nephropathy Macro vascular Coronary artery disease, Peripheral vascular disease & Cerebro-vascular disease. 4. Other chronic debilitating disease like STD etc. 5. Pregnant and lactating women. 6. Tuberculosis and HIV. 7. Patients with Prameha Pidika (carbuncle, furuncles, abscess)

Design outcomes

Primary

MeasureTime frame
Improvement will be assessed on the basis of relief found in cardinal symptoms of disease Progress in the signs and symptoms based on the standard pattern will be applied before and after treatmentTimepoint: 8 weeks

Secondary

MeasureTime frame
Improvement will be assessed on the basis of relief found in cardinal symptoms of disease Progress in the signs and symptoms based on the standard pattern will be applied before and after treatmentTimepoint: 8 weeks

Countries

India

Contacts

Public ContactDr Alankruta R Dave

IPGT and RA GAU Jamnagar

alankruta@yahoo.com9824171817

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026